It can harm the developing fetus or the nursing infant
Assuming Medicare will now cover GLP-1s solely for weight loss, the pressure for employers to provide this coverage may grow
The trial showed that tirzepatide achieved roughly 20% weight loss (about 50 pounds) versus 14% weight loss (33 pounds) with semaglutide. This significant difference prompted analysts to declare tirzepatide the winner. As a result, clinicians are updating treatment algorithms and patients on semaglutide are asking about switching
Mean pain immediately following surgery was 3.51(SD 1.94), 2.63(SD 1.73) on POD1, 2.51(SD 1.57) on POD3, 2.00(SD 1.34) on POD5, and 1.11(SD 0.98) on POD10
Non-obese patients with metabolic syndrome, family history of type 2 diabetes, or documented cardiovascular disease often benefit from GLP-1 therapy as part of comprehensive risk reduction strategies
Ive written about the benefits of B12 shots here, but I will quickly go over the most common benefits that I see in my patients: Increases energy and reduces fatigue Increases metabolism and basal metabolic rate Helps with weight loss Improves sleep and circadian rhythm Increases mood and concentration Boost in immune function Increases hair growth The benefits depend on the person and what symptoms they have prior to taking the B12 shot
